.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
US Department of Justice
US Army
Harvard Business School
Fuji
Farmers Insurance
Johnson and Johnson
Teva
Fish and Richardson
Cerilliant

Generated: June 24, 2017

DrugPatentWatch Database Preview

Ethinyl estradiol; norelgestromin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ethinyl estradiol; norelgestromin and what is the scope of ethinyl estradiol; norelgestromin freedom to operate?

Ethinyl estradiol; norelgestromin
is the generic ingredient in two branded drugs marketed by Mylan Technologies and Janssen Pharms, and is included in two NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for ethinyl estradiol; norelgestromin. Two suppliers are listed for this compound.

Summary for Generic Name: ethinyl estradiol; norelgestromin

Tradenames:2
Patents:1
Applicants:2
NDAs:2
Drug Master File Entries: see list26
Suppliers / Packagers: see list2
Clinical Trials: see list670
Drug Prices:see low prices
DailyMed Link:ethinyl estradiol; norelgestromin at DailyMed

Pharmacology for Ingredient: ethinyl estradiol; norelgestromin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms
ORTHO EVRA
ethinyl estradiol; norelgestromin
FILM, EXTENDED RELEASE;TRANSDERMAL021180-001Nov 20, 2001DISCNYesNo► Subscribe► Subscribe
Mylan Technologies
XULANE
ethinyl estradiol; norelgestromin
FILM, EXTENDED RELEASE;TRANSDERMAL200910-001Apr 16, 2014ABRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ethinyl estradiol; norelgestromin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms
ORTHO EVRA
ethinyl estradiol; norelgestromin
FILM, EXTENDED RELEASE;TRANSDERMAL021180-001Nov 20, 20015,876,746► Subscribe
Janssen Pharms
ORTHO EVRA
ethinyl estradiol; norelgestromin
FILM, EXTENDED RELEASE;TRANSDERMAL021180-001Nov 20, 20015,972,377► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Daiichi Sankyo
UBS
Chubb
Cantor Fitzgerald
Farmers Insurance
QuintilesIMS
Federal Trade Commission
Cipla
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot